PharmaCyte Biotech
PMCB
PMCB
22 hedge funds and large institutions have $4.42M invested in PharmaCyte Biotech in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
Holders
22
Holding in Top 10
–
Calls
$234K
Puts
$140K
Top Buyers
| 1 | +$3.2M | |
| 2 | +$424K | |
| 3 | +$280K | |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$158K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$147K |
Top Sellers
No sellers this quarter